Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey P Sayer

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Australian Family Physician|November 14, 2006
Dosing frequencies in general practice--Whose decision and why?Deborah C Saltman, Geoffrey P Sayer, Natalie A O'Dea
Australian Family Physician|March 3, 2004
Acute bronchitis in Australian general practice. A prescription too far?Nigel P Stocks, Heather McElroy, Geoffrey P Sayer, et al.
The Medical Journal of Australia|October 16, 2003
Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitionersStephen J Kerr, Andrea Mant, Fiona E Horn, et al.
British Journal of Clinical Pharmacology|February 1, 2011
All-cause mortality of elderly Australian veterans using COX-2 selective or non-selective NSAIDs: a longitudinal studyStephen J Kerr, Debra S Rowett, Geoffrey P Sayer, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2003
The General Practice Research Network: the capabilities of an electronic patient management system for longitudinal patient dataGeoffrey P Sayer, Kevin McGeechan, Andrew Kemp, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Australian Family Physician|November 14, 2006
Dosing frequencies in general practice--Whose decision and why?Deborah C Saltman, Geoffrey P Sayer, Natalie A O'Dea
Australian Family Physician|March 3, 2004
Acute bronchitis in Australian general practice. A prescription too far?Nigel P Stocks, Heather McElroy, Geoffrey P Sayer, et al.
The Medical Journal of Australia|October 16, 2003
Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitionersStephen J Kerr, Andrea Mant, Fiona E Horn, et al.
British Journal of Clinical Pharmacology|February 1, 2011
All-cause mortality of elderly Australian veterans using COX-2 selective or non-selective NSAIDs: a longitudinal studyStephen J Kerr, Debra S Rowett, Geoffrey P Sayer, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2003
The General Practice Research Network: the capabilities of an electronic patient management system for longitudinal patient dataGeoffrey P Sayer, Kevin McGeechan, Andrew Kemp, et al.
Pageof 1